Erratum: Effect of TREM-1 blockade and single nucleotide variants in experimental renal injury and kidney transplantation (Scientific Reports (2016) 6 (38275) DOI: 10.1038/srep38275);Effect of TREM-1 blockade and single nucleotide variants in experimental renal injury and kidney transplantation

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Tammaro, A ^a   Kers, J ^a   Emal, D ^a   Stroo, I ^a   Teske, G J D ^a   Butter, L M ^a   Claessen, N ^a   Damman, J ^a   Derive, M ^b   Navis, G ^c   Florquin, S ^a,d   Leemans, J C ^a   Dessing, M C ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b UNIVERSITÉ DE LORRAINE   (France)

^c UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^d RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

FUSION PROTEIN; LAURIC ACID DERIVATIVE; LISSAMINE-RHODAMINE DODECANOIC ACID; RHODAMINE; TRIGGERING RECEPTOR EXPRESSED ON MYELOID CELLS 1;

ANIMAL; ANTAGONISTS AND INHIBITORS; DELAYED GRAFT FUNCTION; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; HUMAN; INFLAMMATION; INJURIES; KIDNEY; KIDNEY TRANSPLANTATION; METABOLISM; MOUSE; PATHOLOGY; REPERFUSION INJURY; SINGLE NUCLEOTIDE POLYMORPHISM;

ANIMALS; DELAYED GRAFT FUNCTION; GENE EXPRESSION REGULATION; HUMANS; INFLAMMATION; KIDNEY; KIDNEY TRANSPLANTATION; LAURIC ACIDS; MICE; POLYMORPHISM, SINGLE NUCLEOTIDE; RECOMBINANT FUSION PROTEINS; REPERFUSION INJURY; RHODAMINES; TRIGGERING RECEPTOR EXPRESSED ON MYELOID CELLS-1;

EID: 85002642244     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep44163     Document Type: Erratum

References (54)

1. Siedlecki, A., Irish, W., Brennan, D. C. Delayed graft function in the kidney transplant. Am. J. Transplant 11, 2279-96 (2011).
2. Cooper, J. E., Wiseman, A. C. Acute kidney injury in kidney transplantation. Curr. Opin. Nephrol. Hypertens. 22, 698-703 (2013).
3. Leemans, J. C., et al. Renal-associated TLR2 mediates ischemia/reperfusion injury in the kidney. J. Clin. Invest. 115, 2894-903 (2005).
4. Pulskens, W. P., et al. Toll-like receptor-4 coordinates the innate immune response of the kidney to renal ischemia/reperfusion injury. PLoS One 3, e3596 (2008).
5. Colonna, M. TREMs in the immune system and beyond. Nat. Rev. Immunol. 3, 445-53 (2003).
6. Sharif, O., Knapp, S. From expression to signaling: roles of TREM-1 and TREM-2 in innate immunity and bacterial infection. Immunobiology 213, 701-13 (2008).
7. Arts, R. J. W., Joosten, L. A. B., van der Meer, J. W. M., Netea, M. G. TREM-1: intracellular signaling pathways and interaction with pattern recognition receptors. J. Leukoc. Biol. 93, 209-15 (2013).
8. Bouchon, A., Dietrich, J., Colonna, M. Cutting edge: inflammatory responses can be triggered by TREM-1, a novel receptor expressed on neutrophils and monocytes. J. Immunol. 164, 4991-5 (2000).
9. Klesney-Tait, J., et al. Transepithelial migration of neutrophils into the lung requires TREM-1. J. Clin. Invest. 123, 138-49 (2013).
10. Hommes, T. J., et al. Role of Triggering Receptor Expressed on Myeloid Cells-1/3 in Klebsiella-Derived Pneumosepsis. Am. J. Respir. Cell Mol. Biol. 53, 647-55 (2015).
11. Weber, B., et al. TREM-1 deficiency can attenuate disease severity without affecting pathogen clearance. PLoS Pathog. 10, e1003900 (2014).
12. Gibot, S., et al. Effects of the TREM-1 pathway modulation during mesenteric ischemia-reperfusion in rats. Crit. Care Med. 36, 504-10 (2008).
13. Boufenzer, A., et al. TREM-1 Mediates Inflammatory Injury and Cardiac Remodeling Following Myocardial Infarction. Circ. Res. 116, 1772-82 (2015).
14. Campanholle, G., et al. TLR-2/TLR-4 TREM-1 signaling pathway is dispensable in inflammatory myeloid cells during sterile kidney injury. PLoS One 8, e68640 (2013).
15. Tammaro, A., et al. Role of TREM1-DAP12 in Renal Inflammation during Obstructive Nephropathy. PLoS One 8, e82498 (2013).
16. Lo, T.-H., et al. TREM-1 regulates macrophage polarization in ureteral obstruction. Kidney Int. 86, 1174-86 (2014).
17. Bonventre, J., Yang, L. Cellular pathophysiology of ischemic acute kidney injury. J. Clin. Invest. 121, (2011).
18. Ornatowska, M., et al. Functional genomics of silencing TREM-1 on TLR4 signaling in macrophages. Am. J. Physiol. Lung Cell. Mol. Physiol. 293, L1377-84 (2007).
19. Klesney-Tait, J., Colonna, M. Uncovering the TREM-1-TLR connection. Am. J. Physiol. Lung Cell. Mol. Physiol. 293, L1374-6 (2007).
20. Schiechl, G., et al. Inhibition of Innate Co-Receptor TREM-1 Signaling Reduces CD4(+ ) T Cell Activation and Prolongs Cardiac Allograft Survival. Am. J. Transplant 13, 1168-80 (2013).
21. Wu, J., et al. The proinflammatory myeloid cell receptor TREM-1 controls Kupffer cell activation and development of hepatocellular carcinoma. Cancer Res. 72, 3977-86 (2012).
22. Derive, M., et al. Effects of a TREM-like transcript 1-derived peptide during hypodynamic septic shock in pigs. Shock 39, 176-82 (2013).
23. Derive, M., Boufenzer, A., Gibot, S. Attenuation of responses to endotoxin by the triggering receptor expressed on myeloid cells-1 inhibitor LR12 in nonhuman primate. Anesthesiology 120, 935-42 (2014).
24. Gibot, S., et al. Modulation of the triggering receptor expressed on the myeloid cell type 1 pathway in murine septic shock. Infect. Immun. 74, 2823-30 (2006).
25. Dessing, M. C., et al. Toll-Like Receptor Family Polymorphisms Are Associated with Primary Renal Diseases but Not with Renal Outcomes Following Kidney Transplantation. PLoS One 10, e0139769 (2015).
26. Dessing, M. C., et al. The calcium-binding protein complex S100A8/A9 has a crucial role in controlling macrophage-mediated renal repair following ischemia/reperfusion. Kidney Int. 87, 85-94 (2015).
27. Stroo, I., et al. Chemokine expression in renal ischemia/reperfusion injury is most profound during the reparative phase. Int. Immunol. 22, 433-42 (2010).
28. Gómez-Pinã, V., et al. Role of MMPs in orchestrating inflammatory response in human monocytes via a TREM-1-PI3K-NF-B pathway. J. Leukoc. Biol. 91, 933-45 (2012).
29. Baruah, S., et al. Identification of a Novel Splice Variant Isoform of TREM-1 in Human Neutrophil Granules. J. Immunol. 195, 5725-31 (2015).
30. Gibot, S., et al. Soluble triggering receptor expressed on myeloid cells and the diagnosis of pneumonia. N. Engl. J. Med. 350, 451-8 (2004).
31. Gibot, S. Plasma Level of a Triggering Receptor Expressed on Myeloid Cells-1: Its Diagnostic Accuracy in Patients with Suspected Sepsis. Ann. Intern. Med. 141, 9 (2004).
32. Su, L., et al. Diagnostic value of urine sTREM-1 for sepsis and relevant acute kidney injuries: a prospective study. Crit. Care 15, R250 (2011).
33. Tzivras, M., et al. Role of soluble triggering receptor expressed on myeloid cells in inflammatory bowel disease. World J. Gastroenterol. 12, 3416-9 (2006).
34. Kamei, K., et al. Role of triggering receptor expressed on myeloid cells-1 in experimental severe acute pancreatitis. J. Hepatobiliary. Pancreat. Sci. 17, 305-12 (2010).
35. Gibot, S., et al. Modulation of the triggering receptor expressed on myeloid cells-1 pathway during pneumonia in rats. J. Infect. Dis. 194, 975-83 (2006).
36. Wiersinga, W. J., et al. Expression profile and function of triggering receptor expressed on myeloid cells-1 during melioidosis. J. Infect. Dis. 196, 1707-16 (2007).
37. Gibot, S., et al. Effects of the TREM 1 pathway modulation during hemorrhagic shock in rats. Shock 32, 633-7 (2009).
38. Schenk, M., Bouchon, A., Seibold, F., Mueller, C. TREM-1-expressing intestinal macrophages crucially amplify chronic inflammation in experimental colitis and inflammatory bowel diseases. J. Clin. Invest. 117, 3097-106 (2007).
39. Murakami, Y., et al. Intervention of an inflammation amplifier, triggering receptor expressed on myeloid cells 1, for treatment of autoimmune arthritis. Arthritis Rheum. 60, 1615-23 (2009).
40. Bouchon, A., Facchetti, F., Weigand, M. A., Colonna, M. TREM-1 amplifies inflammation and is a crucial mediator of septic shock. Nature 410, 1103-7 (2001).
41. Wong-Baeza, I., et al. Triggering receptor expressed on myeloid cells (TREM-1) is regulated post-transcriptionally and its ligand is present in the sera of some septic patients. Clin. Exp. Immunol. 145, 448-55 (2006).
42. Chen, L. C., Laskin, J. D., Gordon, M. K., Laskin, D. L. Regulation of TREM expression in hepatic macrophages and endothelial cells during acute endotoxemia. Exp. Mol. Pathol. 84, 145-55 (2008).
43. Wu, H., et al. TLR4 activation mediates kidney ischemia/reperfusion injury. J. Clin. Invest. 117, 2847-59 (2007).
44. Hirayama, K., et al. Serum ratio of soluble triggering receptor expressed on myeloid cells-1 to creatinine is a useful marker of infectious complications in myeloperoxidase-antineutrophil cytoplasmic antibody-associated renal vasculitis. Nephrol. Dial. Transplant 26, 868-74 (2011).
45. Essa, E. S., Elzorkany, K. M. A. sTREM-1 in patients with chronic kidney disease on hemodialysis. APMIS 123, 969-74 (2015).
46. Jung, E. S., et al. Relationships between genetic polymorphisms of triggering receptor expressed on myeloid cells-1 and inflammatory bowel diseases in the Korean population. Life Sci. 89, 289-94 (2011).
47. Rivera-Chávez, F. A., et al. A TREM-1 Polymorphism A/T within the Exon 2 Is Associated with Pneumonia in Burn-Injured Patients. ISRN Inflamm. 2013, 431739 (2013).
48. Su, L., et al. Dynamic changes in serum soluble triggering receptor expressed on myeloid cells-1 (sTREM-1) and its gene polymorphisms are associated with sepsis prognosis. Inflammation 35, 1833-43 (2012).
49. Golovkin, A. S., et al. Association of TLR and TREM-1 gene polymorphisms with risk of coronary artery disease in a Russian population. Gene 550, 101-9 (2014).
50. Golovkin, A. S., et al. An association between single nucleotide polymorphisms within TLR and TREM-1 genes and infective endocarditis. Cytokine 71, 16-21 (2015).
51. Chen, Q., et al. Lack of association between TREM-1 gene polymorphisms and severe sepsis in a Chinese Han population. Hum. Immunol. 69, 220-6 (2008).
52. Liu, J., et al. Cell-specific translational profiling in acute kidney injury. J. Clin. Invest. 124, 1242-54 (2014).
53. Damman, J., et al. Crosstalk between complement and Toll-like receptor activation in relation to donor brain death and renal ischemia-reperfusion injury. Am. J. Transplant 11, 660-9 (2011).
54. Purcell, S., et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am. J. Hum. Genet. 81, 559-75 (2007).